← Oncology Approval Tracker

FDA DECISION ·

Ponatinib tablets

ponatinib · Apotex

First generic approvalFirst genericChronic myeloid leukemia and acute lymphoblastic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic 15 mg and 45 mg tablets for adults with chronic-phase CML resistant or intolerant to at least two kinase inhibitors, advanced-phase CML or Ph-positive ALL when no other kinase inhibitor is indicated, or T315I-positive CML or Ph-positive ALL.

LAMPGEN ANALYSIS

Why it matters

The decision added a generic BCR::ABL1 inhibitor for labeled leukemia settings.

What research teams should watch

Check the approved strengths, disease phase and prior TKI history, and distinguish final approval from commercial launch.

PRIMARY RECORDS

Sources